Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Eaton

Showing results (291-300 of 318) with videos related to

Pageof 32
Sort By:
Genes & Development|August 22, 2020
<i>MYCN</i> drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivityEli Grunblatt, Nan Wu, Huajia Zhang, et al.
HIV Medicine|May 23, 2025
"They didn't think we'd live this long": A qualitative exploration of older adults living with HIV perspectives on geriatric care in OntarioKristina M Kokorelias, Dean Valentine, Andrew D Eaton, et al.
JMIR Aging|May 27, 2025
Socioculturally Appropriate Internet-Based Geriatric Care Model for Older Adults Living With HIV: Experience-Based Co-Design ApproachKristina M Kokorelias, Marina B Wasilewski, Dean Valentine, et al.
Scientific Reports|August 17, 2017
Development of a Primary Human Co-Culture Model of Inflamed Airway MucosaLael M Yonker, Hongmei Mou, Kengyeh K Chu, et al.
BMJ Open|February 4, 2026
Culturally appropriate sexual health interventions for STBBI and HIV among racialised immigrant communities in Western nations: a scoping review protocolAbukari Kwame, Geoffrey Maina, Erin Langman, et al.
Future Oncology (London, England)|November 8, 2024
Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib studyLyudmila Bazhenova, Dong-Wan Kim, Byoung Chul Cho, et al.
Cancer Medicine|March 29, 2022
Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patientsCameron Chalker, Jenna M Voutsinas, Qian Vicky Wu, et al.
Journal of Palliative Medicine|December 1, 2021
High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint InhibitorsCameron Chalker, Rafael Santana-Davila, Jenna M Voutsinas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 14, 2026
Interrogating the mechanistic link between neighborhood deprivation and colorectal cancer risk through transcriptomic analysis of normal colorectal biopsiesMatthew A Devall, Hania M Taha, Mackenzie Chen, et al.
Advances in Radiation Oncology|April 7, 2022
Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung CancerStephen R Bowen, Daniel S Hippe, Hannah M Thomas, et al.
Pageof 32

Showing results (291-300 of 318) with videos related to

Sort By:
Pageof 32
Genes & Development|August 22, 2020
<i>MYCN</i> drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivityEli Grunblatt, Nan Wu, Huajia Zhang, et al.
HIV Medicine|May 23, 2025
"They didn't think we'd live this long": A qualitative exploration of older adults living with HIV perspectives on geriatric care in OntarioKristina M Kokorelias, Dean Valentine, Andrew D Eaton, et al.
JMIR Aging|May 27, 2025
Socioculturally Appropriate Internet-Based Geriatric Care Model for Older Adults Living With HIV: Experience-Based Co-Design ApproachKristina M Kokorelias, Marina B Wasilewski, Dean Valentine, et al.
Scientific Reports|August 17, 2017
Development of a Primary Human Co-Culture Model of Inflamed Airway MucosaLael M Yonker, Hongmei Mou, Kengyeh K Chu, et al.
BMJ Open|February 4, 2026
Culturally appropriate sexual health interventions for STBBI and HIV among racialised immigrant communities in Western nations: a scoping review protocolAbukari Kwame, Geoffrey Maina, Erin Langman, et al.
Future Oncology (London, England)|November 8, 2024
Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib studyLyudmila Bazhenova, Dong-Wan Kim, Byoung Chul Cho, et al.
Cancer Medicine|March 29, 2022
Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patientsCameron Chalker, Jenna M Voutsinas, Qian Vicky Wu, et al.
Journal of Palliative Medicine|December 1, 2021
High End-of-Life Health Care Utilization in a Contemporary Cohort of Head and Neck Cancer Patients Treated with Immune Checkpoint InhibitorsCameron Chalker, Rafael Santana-Davila, Jenna M Voutsinas, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 14, 2026
Interrogating the mechanistic link between neighborhood deprivation and colorectal cancer risk through transcriptomic analysis of normal colorectal biopsiesMatthew A Devall, Hania M Taha, Mackenzie Chen, et al.
Advances in Radiation Oncology|April 7, 2022
Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung CancerStephen R Bowen, Daniel S Hippe, Hannah M Thomas, et al.
Pageof 32